About Slate Medicines
Slate Medicines is a private company based in Boston, Massachusetts, incorporated in 2024 in Delaware. It has reported $9,999,992 raised in one offering on Form D since March 2026. Its chief executive is Gregory Oakes.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Mar 11, 2026 | $9,999,992of $130.0M target | 6 | $1.6M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Slate Medicines's Form D filed Mar 11, 2026.
Sources
- SECSlate Medicines, Inc. filing history
- CompanyTerms of use
- CompanyGregory Oakes
- CompanyMerger agreement announcement